European Monitoring Centre for Drugs and Drug Addiction. EMCDDA-Europol 2011 Annual Report on the Implementation of Council Decision 2005/387/JHA. EMCDDA/Europol, 2012.
HM Government. Drug Strategy 2010. Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life. Home Office, 2010.
House of Commons Home Affairs Committee. Drugs: Breaking the Cycle. Ninth Report of Session 2012–13. Home Affairs Committee, 2012.
UK Drug Policy Commission. Taking Drugs Seriously: A Demos and UK Drug Policy Commission Report on Legal Highs. UKDPC, 2011.
Home Office. Drug Misuse Declared: Findings from the 2011/12 Crime Survey for England and Wales (2nd edn). Home Office, 2012.
Advisory Council on the Misuse of Drugs. Consideration of the Novel Psychoactive Substances (‘Legal Highs’). Advisory Council on the Misuse of Drugs, 2011.
National Treatment Agency for Substance Misuse. Drug Treatment 2012: Progress Made, Challenges Ahead. NTA, 2012.
National Treatment Agency for Substance Misuse. Club Drugs: Emerging Trends and Risks. NTA, 2012.
UK Drug Policy Commission. The Impact of Drugs on Different Minority Groups: LGBT Groups. UKDPC, 2010.
Ghodse, H, Corkery, J, Schifano, F, Piolanti, A, Trincas, G, Di Melchiorre, G.
Drug-Related Deaths in the UK, Annual Report 2011. International Centre for Drug Policy, St George's, University of London, 2012.
Shahani, R, Streutker, C, Dickson, B, Stewart, RJ. Ketamine-associated ulcerative cystitis: a new clinical entity. Urology
2007; 69: 810–2.
Gutkin, E, Hussain, SA, Kim, SH. Ketamine-induced biliary dilatation: from Hong Kong to New York. J Addict Med
2012; 6: 89–91.
Galloway, GP, Frederick, SL, Staggers, FE Jr, Gonzales, M, Stalcup, SA, Smith, DE. Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction
1997; 92: 89–96.
DrugScope. DrugScope Street Drug Trends Survey. Druglink